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Abstract
Dendritic cells (DCs) are well known as professional antigen-presenting cells (APC) able to initiate specific T-cell responses to
pathogens in lymph nodes (LN) draining the site of infection. However, the respective contribution of migratory and LN-
resident DCs in this process remains unclear. As DC subsets represent important targets for vaccination strategies, more
precise knowledge of DC subsets able to present vaccine antigens to T cells efficiently is required. To investigate the
capacities of DCs migrating in the lymph (L-DCs) to initiate a specific T-cell response, we used physiologically generated DCs
collected from a pseudoafferent lymphatic cannulation model in sheep. The CD1b
+ L-DCs were assessed for presenting
antigens from the vaccine attenuated strain of Salmonella enterica serovar Abortusovis. CD1b
+ L-DCs were able to
phagocytose, process and to present efficiently Salmonella antigens to effector/memory T cells in vitro. They were shown to
be efficient APC for the priming of allogeneic naive T cells associated with inducing both IFN-c and IL-4 responses. They
were also efficient in presenting Salmonella antigens to autologous naive T cells associated with inducing both IFN-c and IL-
10 responses. The capacities of L-DCs to process and present Salmonella antigens to T cells were investigated in vivo after
conjunctival inoculation of Salmonella. The CD1b
+ L-DCs collected after inoculation were able to induce the proliferative
response of CD4
+ T cells suggesting the in vivo capture of Salmonella antigens by the CD1b
+ L-DCs, and their potential to
present them directly to CD4
+ T cells. In this study, CD1b
+ L-DCs present potential characteristics of APC to initiate by
themselves T cell priming in the LN. They could be used as target cells for driving immune activation in vaccinal strategies.
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Introduction
Dendritic cells (DCs) are well known as professional antigen-
presenting cells (APC) able to initiate specific T-cell responses to
pathogens in lymph nodes (LN) draining the site of infection.
However, the respective contribution of migratory and LN-
resident DCs in this process remains unclear [1]. Moreover, the
understanding of this complex process depends on the different
DC subsets described. In mice, there are migratory DC subsets
including epidermal Langerhans cells (LCs), CD11b
+ CD103
2
and CD11b
2 CD103
+ dermal DCs, LN-resident DCs compris-
ing both CD8a
+ and CD8a
2 DCs, and inflammatory DCs
recruited during infection [2,3]. Studies based on experimental
mouse models of cutaneous infection support the role of LCs in
antigen (Ag) transport to the peripheral LN but not directly in
the induction of pathogen-specific T-cell responses [4,5].
Numerous studies examining the role of migratory and LN-
resident DCs in the induction of CD8
+ T cell-mediated
immunity to viruses after cutaneous infection have shown the
exclusive cross-presentation of Ag by CD8a
+ DCs resident in
LN, and the role of migratory DCs in delivering and transferring
Ag to resident CD8a
+ DCs [3]. However, these conclusions may
not be applicable to the priming of cytotoxic T-lymphocyte
(CTL) responses to all viruses since migratory skin DCs have
been shown to present lentivirus-derived ovalbumin (OVA)
directly to LN CD8
+ T cells [6], or at least in cooperation with
LN-resident DCs [7]. Moreover, dermal migratory DCs have
been shown to play a role in generating CD4
+ T-cell responses
following subcutaneous (SC) influenza infection [8]. Regarding
the LN-resident DCs, CD8a
2 DCs seem to be more efficient
than CD8a
+ DCs at presenting exogenous antigens by MHCII
molecules [9]. For Salmonella, the involvement of both CD8a
+
and CD8a
2 splenic DCs in the priming of T cells was reported
in mice, but the involvement of migratory DC subsets was not
investigated [10]. The respective contribution of migratory and
LN-resident DCs in T-cell priming is thus dependent on the
pathogen encountered, but also influenced by the in vivo infection
route. Herpes simplex virus (HSV) is rapidly presented by LN-
resident DCs [11] or dermal DCs [12] to CD4
+ and CD8
+ T
cells after SC injection, whereas HSV Ag is mainly presented by
migratory DCs after mucosal administration [11].
Most of these studies were performed in mouse models using
diverse experimental strategies. Although these models assessed in
detail the diverse functions of migratory DC subsets isolated from
tissues, they did not investigate them in the draining lymph directly
before their arrival in the LN. As DCs are important targets for
vaccination strategies, more precise knowledge of DC subsets able
to present vaccine antigens to T cells efficiently is required.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30430Moreover, attenuated pathogens such as Salmonella can be
attractive as a vehicle to deliver Ag to the appropriate DCs
involved in a protective immune response.
These questions can be investigated further in large animals,
using physiologically generated DCs collected from a pseudoaf-
ferent lymphatic cannulation model [13,14]. The ruminant lymph
DCs (L-DCs) were originally defined on the expression of the
CD1b and CD14 molecules [15]. Several studies have investigated
and showed the capacities of L-DCs to acquire soluble antigen in
vitro or in vivo and to present it directly and specifically to
autologous T cells [14]. More recent studies have described
different L-DC subsets including plasmacytoid [16] and CD8a-like
DCs [17]. However, a few studies have analyzed the interaction
between DCs and Salmonella, and their involvement in the priming
of naive T cells in vivo [10]. An in vitro study showed that fewer
Salmonellae were taken up by CD1b
+ L-DCs than by monocyte-
derived macrophages [18]. Moreover, one of our in vivo studies
showed that CD1b
+ L-DCs did not play a major role in Salmonella
transport to LN after SC infection of the upper respiratory tract
with a live vaccine, despite an increased flow of these cells in the
lymph [19]. This study showed the predominant role of
neutrophils in the the live vaccine uptake as it was also showed
in another study using particulate antigen [20]. This approach can
assess directly the ability of migratory L-DC subsets to perform Ag
presentation at steady state and under infectious conditions.
The aim of this study was to investigate in detail the capacity of
sheep CD1b
+ L-DCs, collected from afferent lymph draining the
skin or the head mucosae, to present Salmonella antigens to T cells
in vitro and in vivo after mucosal administration. To this end, we
used the vaccine-attenuated strain of Salmonella demonstrated to
induce protection against abortive salmonellosis in sheep [21], and
previously used to assess the capacity of L-DCs to uptake and
transport Salmonella to LN [19].
Materials and Methods
Ethics statement
The animal experiments were conducted under a license issued
by the Direction des Services Ve ´te ´rinaires of Tours (accreditation
B-37-175-3) and were approved by the Regional Centre-Limousin
Ethics Committee (CL2006-012).
Sheep and surgery
‘Prealpes du sud’ ewes (one to four years old) originating from
the Unite ´ Commune d’Expe ´rimentation Animale (INRA, Jouy-en-
Josas, France) or from the Plateforme d’Infectiologie Expe ´rimen-
tale (PFIE) (INRA, Nouzilly, France), were housed in the PFIE for
surgery and Salmonella infection. They were born and raised in
salmonellosis-free herds. Prescapular lymph duct cannulation was
performed on the right side of the sheep to collect pseudo-afferent
lymph from skin as described previously [13], and cervical lymph
duct cannulation was performed on the left side of the same sheep,
to collect lymph from the head mucosae as described previously
[22]. A total of 11 sheep were used for the study, of which eight
were successfully cannulated. Sheep received a daily subcutaneous
(SC) injection of calcium heparin (300U per kg per day)
(CalciparineH, Sanofi-Avantis, France).
Collection of lymph and lymph cell storage
Lymph was collected continuously in 250 ml sterile polypropylene
flasks containing 10 ml of buffered saline supplemented with
antibiotics (100 IU/ml of penicillin and 100 mg/ml of streptomycin,
Sigma-Aldrich, St Louis, MO) and sodium heparin (250 IU/ml)
(he ´parine choayH, Sanofi-Avantis, France) to prevent both bacterial
contamination and clotting. Flasks were changed twice a day, the
lymph volume was determined and the viable cell number was
assessed using the trypan blue dye exclusion test. Lymph cells were
spun down at 400 g for five min, step-frozen in fetal calf serum (FCS)
containing 10% dimethyl sulfoxide, and kept in liquid nitrogen. All
the analyses described hereafter were performed on lymph cells from
frozen samples. Over 95% viability was obtained after thawing.
Phenotypic analysis of lymph DC cells (L-DCs) by flow
cytometry
Lymph cells were thawed, washed once in HANK’S Balanced
Salts (HBSS) medium supplemented with 2.5% FCS, 20 IU/ml of
penicillin and 20 mg/ml of streptomycin (HBSS–FCS) and
adjusted to 5610
6 cells/ml. Labelling was performed in 96
round-bottom well microplates (BD Falcon
TM, Becton Dickinson,
Franklin Lakes, NJ) using 5610
5 cells per well. Cells were
incubated with 50 ml of antibodies diluted at optimal concentra-
tions in RPMI 1640 medium (Life Technologies, Cergy Pontoise,
France) supplemented with 10% FCS, 2 mM L-glutamine, 1mM
sodium pyruvate, and 50 mM ß-mercaptoethanol, 20 IU/ml of
penicillin and 20 mg/ml of streptomycin (complete medium) for
20 min on ice with gentle stirring, and washed three times with
HBSS–FCS after each step.
Cells were first incubated with one of the primary or
appropriate isotype control monoclonal antibodies (mAbs) at
equivalent concentrations to primary mAbs (Table 1) and then
with R-Phycoerythrin (RPE)-conjugated F(ab’)2 fragment goat
anti-mouse (GAM) IgG (1:200) (Jackson ImmunoResearch,
Suffolk, UK). Cells were further incubated with anti-CD1b mAb
(Table 1) followed by FITC-conjugated GAM IgG2a (1:200)(Cal-
tag Laboratories, Burlingame, CA). After washes, cells were
resuspended and fixed in 100 ml of 1% paraformaldehyde in
buffered saline. Thirty to sixty thousand events were analysed with
a FACSCalibur
TM (Becton Dickinson) using the CellQuestPro
TM
software analysis programme (Becton Dickinson).
Cells were analysed in a cell population gated on the basis of
forward and scattered angles. The CD1b
+ L-DCs were selected
with appropriate gating and analysed for the expression of
different markers.
L-DC subsets sorting using fluorescence-activated cell
sorting
Lymph cells were quickly thawed and washed once in HBSS-
FCS. To deplete lymphocytes, cells were first incubated with a
mixture of mAbs including anti-ruminant CD4 (17D1), CD8, cd
TCR, CD45R (2 mg/ml of each mAb for 1610
8 cells) (Table 1) for
20 min on ice with gentle stirring, washed three times with HBSS–
FCS followed by RPE-conjugated GAM IgG labelling. Cells were
further incubated with anti- CD1b mAb, followed by FITC-
conjugated GAM IgG2a. After three washes with HBSS–FCS,
cells were resuspended in RPMI medium without FCS before
sorting. Appropriate IgG1 and IgG2a isotypes (Table 1) were used
at equivalent concentrations to the primary mAbs to produce
controls. CD1b
+ L-DCs were sorted using a fluorescence-activated
cell sorter (MoFloH, DakoCytomation, 4850 Innovation Drive,
Fort Collins, CO) after gating on a population negative for
lymphocyte markers and positive for CD1b. The proportion of the
CD1b
+ L-DCs subset was enriched from 1% in the lymph to 96%
with an average purity of over 98%.
RNA extractions and reverse transcriptase PCR (RT-PCR)
Messenger RNA was extracted from sorted CD1b
+ L-DCs using
the DynabeadsH mRNA DIRECT
TM Micro Kit (Invitrogen
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transcription with MuMLV reverse transcriptase (25U/ml) (Euro-
gentec, Lie `ge, Belgium) and Oligo-dT (133 pmole/ml) (Euro-
gentec). The reaction was maintained for 90 min at 37uC and then
heat-inactivated at 85uC for 10 min. The generated cDNA was
then analysed for the presence of sequences encoding for DC-
SIGN, CD103, CCR7, glyceraldehydes-3-phosphate dehydroge-
nase (GAPDH) and hypoxanthine-guanine phosphoribosyltrans-
ferase (HPRT) by either end-point or real-time quantitative PCR.
The cDNA control was produced as described above from ovine
spleen cells stimulated by both LPS and Concanavalin A. Primers
(Table 2) were designed using Clone Manager 9 (Scientific &
Educational Software, Cary, NC) and purchased from Euro-
gentec. DNA was amplified with REDTaq
TM DNA Polymerase
(1U/mL) (D5684, Sigma-Aldrich) for 34 cycles at the appropriate
annealing temperature for 60 s (Table 2) and at 72uC for 60 s.
PCR products were run on 1% agarose gel with ethidium bromide
staining.
Quantitative real-time PCR (qPCR) was carried out using
diluted cDNA, in duplicate, with the IQ SYBR Green Supermix
(Bio-Rad, Hercules, CA) following the manufacturer’s recommen-
dations. Cycling conditions were 95uC for five min, followed by 39
cycles with denaturation at 95uC for 10 s and the appropriate
annealing temperature (Table 2) for 15 s. PCR reactions were run
on a Bio-Rad iCycler iQ (Bio-Rad). The specificity of the qPCR
reactions was assessed by analysing the melting curves of the
products and size verification. Samples were normalized internally
using the cycle quantification (Cq) of GAPDH and HPRT
simultaneously as references in each sample. Cq values were
extracted with the qPCR instrument software and subsequently
imported into qbase
PLUS (http://www.qbaseplus.com) for quality
control and generation of the standard curves. Relative quantities
were calculated using the qBase quantification model which
enables PCR efficiency correction, multiple reference assay
normalization, proper error propagation and, if necessary, inter-
run calibration [23].
Lymphocyte subset sorting using immunomagnetic
microbeads
Peripheral blood mononuclear cells (PBMC) were obtained
from fresh blood diluted 1/2 in phosphate buffered saline without
calcium and magnesium (PBS) and layered onto HistopaqueH
1077 (density 1.077, Sigma-Aldrich). After centrifugation at 1600g
for 20 min at room temperature, PBMC were harvested at the
interface and washed three times in HBSS-FCS. For the positive
selection of CD4
+ or CD62L
+ T cells, PBMC were then incubated
with anti- CD4 (SBUT4) or anti- CD62L mAb (Table 1), washed
three times in PBS supplemented with 0.5% bovine serum
albumin (BSA, A7906, Sigma-Aldrich), and further incubated
with GAM IgG (H+ L)-coated magnetic microbeads according to
Table 1. Primary antibodies.
Specificity Clone Isotype Designation Source
Bovine CD1b Th97A IgG2a Th97A VMRD
a
Ovine CD4 17D1 IgG1 17D1 VMRD
Ovine CD4 SBUT4 IgG1+IgG2a SBUT4 Melbourne University
Ovine CD62L DU1-29 IgG1 DU1-29 VMRD
Bovine CD8ß CC58 IgG1 MCA1654 Serotec
b
Bovine CD11b MM12A IgG1 MM12A VMRD
Ovine CD11c 129F7 IgG1 OM1 M. Pe ´pin
c
Ovine CD14 VPM65 IgG1 VPM65 J. Hopkins
d
Bovine CD26 CC69 IgG1 MCA1652 Serotec
Bovine CD40 ILA156 IgG1 ILA156 J. Hope
e
Bovine CD44 BAT31A IgG1 BAT31A VMRD
Ovine CD45R 20.96 IgG1 MCA2221 Serotec
Bovine CD80 ILA159 IgG1 ILA159 J. Hope
Bovine CD86 ILA190 IgG1 ILA190 J. Hope
Bovine CD205 CC98 IgG2b MCA1651 Serotec
Human CD206 ILA190 IgG1 ILA190 J. Hope
Human CD209 AHP627 Poly IgG AHP627 Serotec
Bovine cd TCR 86D IgG1 86D VMRD
Ovine MHCII SBU2 IgG1 28.1 Serotec
Bovine SIRP-a ILA24 IgG1 ILA-24 J. Hope
Isotype control X0931 IgG1 X0931 DakoCytomation
f
Isotype control X0943 IgG2a X0943 DakoCytomation
aVMRD, Pullman, WA.
bSerotec, Du ¨sseldorf, Germany.
cM. Pe ´pin, ENVL, France.
dJ. Hopkins, University of Edinburgh, UK.
eJ. Hope, IAH Compton, UK.
fDakoCytomation, Fort Collins, CO.
doi:10.1371/journal.pone.0030430.t001
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crobeads, 130-048-402, Miltenyi Biotec, Paris, France). After three
washes, cells were positively selected with an MS column and
octoMACS
TM separator (Miltenyi Biotec), and the efficiency of the
resulting positive selection was checked by flow cytometry after
incubating the sorted cells with RPE-conjugated GAM IgG
(Table 1). The purity of CD4
+ T cells and CD62L
+ T cells were on
average over 96% and 90% respectively.
Preparation of Salmonella and infection
The Salmonella enterica serovar Abortusovis Rv-6 strain is a live
attenuated vaccinal strain described previously [19] and stored in
aliquots at 280uC in 10% glycerol-buffered saline. Aliquots were
thawed, washed in buffered saline and the bacterial suspension
adjusted to the appropriate concentration for each experiment.
For in vivo infection, sheep were inoculated either by the SC route
behind each shoulder with 1 ml containing 0.5 to 0.8610
9
Salmonella, or by the conjunctival route with 1.2610
9 Salmonella
administered in four drops of 50 ml in the left eye drained by the
cannulated cervical duct. The administration of Salmonella by the
conjunctival route was carried out after cervical cannulation, and
lymph was collected for 72 hours for analysis. For the in vitro
experiment with L-DCs, the bacterial suspension was adjusted to
the appropriate concentration in complete medium without
antibiotics. The GFP-Salmonella Rv-6 strain, obtained by transfor-
mation with the plasmid pBRD940 [18], was also used for
phagocytosis assays. The purity of the Salmonella culture and the
number of viable bacteria were checked by plating serial dilutions
on tryptic soy agar (TSA, Difco Laboratories, Detroit, MI).
Endocytosis and phagocytosis assays
FITC-conjugated ovalbumin (FITC-OVA, 0-23020, Molecular
ProbesH, Invitrogen) was used to examine the endocytic ability of
the L-DCs. Lymph cells were adjusted to 1610
6 cells/ml of
complete medium and incubated at 37uCo r4 uC for one hour with
200 mL of FITC-OVA (50 mg/ml) [24]. Controls included cells
incubated at 37uC and 4uC without FITC-OVA. For phagocytosis
assays, lymph cells were infected by Salmonella (100 bacteria/cell)
for 30 min at 37uC. Cells were then washed with medium
supplemented with gentamicin (G1397, Sigma-Aldrich) once at
200 mg/ml and twice at 50 mg/ml to remove and kill any
remaining extracellular bacteria. Cells were then washed with
HBSS-FCS and first incubated with anti-CD1b mAb followed by
RPE-conjugated GAM IgG (Table 1). After washes, cells were
incubated with a mixture of mAbs including anti-ruminant CD4,
CD8, cd TCR, CD45R labelled with the Alexa FluorH 647 using
the monoclonal antibody labelling kit according to the manufac-
turer’s recommendations (A-20186, Molecular ProbesH, Invitro-
gen). After washes, cells were resuspended and fixed in 100 mlo f
1% paraformaldehyde in buffered saline. Thirty thousand events
were analysed using FACS. The CD1b
+ L-DCs were selected with
appropriate gating, and the proportion of FITC labelled cells was
analysed.
Antigen presentation assays by L-DCs
To assess the allogeneic reaction, sorted CD1b
+ L-DCs were
resuspended in complete medium and seeded in triplicates
(100 ml/well) at different ratios in round-bottom plates (Falcon
3077, Becton Dickinson) for 24h at 37uC. Purified allogeneic
CD4
+ or CD62L
+ T cells (1610
5/100 ml/well) were then added to
CD1b
+ L-DCs. After 72h, 150 ml of supernatant were harvested
and frozen at –80uC for cytokine detection, and 150 ml of fresh
complete medium were added. The co-cultures were further
incubated for 72h and proliferation was assessed by [
3H]-
thymidine incorporation (1 mCi/3.7610
4 Bq, NEN Research
Products, Paris, France) for the last eight hours of culture followed
by scintillation counting (Packard 1600TR meter, Meriden, CT).
To assess Salmonella presentation, CD1b
+ L-DCs were resus-
pended in complete medium without antibiotics, distributed in
round-bottom plates (1610
3/well) and infected by Salmonella as
described above. After washes with antibiotics to remove and kill
any remaining extracellular bacteria, cells were resuspended in
complete medium supplemented with gentamicin (50 mg/ml)
(100 ml) and incubated for 24h at 37uC. Autologous purified T-
cell subsets (1610
5 cells/well) were added to the DCs (100 ml/well)
and co-cultured for six days. After 72h, 150 ml of supernatant was
harvested and frozen at –80uC for cytokine detection and 150 mlo f
fresh complete medium was added. The proliferative response was
assessed by [
3H]-thymidine incorporation for the last eight hours
of culture followed by scintillation counting.
Cytokine detection
IFN-c was detected by ELISA using a sandwich ELISA with
mAbs developed against bovine IFN-c [25]. Flat-bottomed
Maxisorp plates (442404, Nunc, Roskilde, Denmark) were coated
with the capture anti- IFN-c CC330 mAb (100 ml/well) (Serotec,
Oxford, UK) at 2 mg/ml diluted in PBS and incubated overnight
at 4uC. After washes with PBS containing 0.05% Tween20
Table 2. Primers used for PCR and real-time RT-PCR analysis.
Target mRNA Primer sequence Annealing temperature (6C) PCR product (bp) Accession number
CCR7 S:GGGAAGCCAATGAAGAAC 60 185 AY834253
AS:TACATGATCGGGAGGAAC
CD103 S:GACAGCCAAGACGTTAGAG 58 205 XM2695790
AS:TGACAGTCGTGAGGTTGAG
DC-SIGN S: GAGACCGTGAGAACAACAG 58 206 EU431222
AS:GGTCCAGGAGAAGAAGTAG
GAPDH S:GGCGTGAACCACGAGAAGTATAA 60 119 NM1190390
AS: CCCTCCACGATGCCAAAGT
HPRT S: AAACCAAAGATGGTCAAGGT 56 200 BC103248
AS: TCTTAGGCTTTGTATTTTGCTT
doi:10.1371/journal.pone.0030430.t002
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+ L-DCs are migratory mature DC capable of endocytic and phagocytic activities. After labelling lymph cells with anti-
CD1b mAb (A), CD1b
+ L-cells were gated and analysed for the expression of different markers. Data express the median (quartiles) of the percentage
of positive cells from 3 sheep (B). Plots of different markers expressed by CD1b
+ L-DCs are shown (C). May-Gru ¨nwald Giemsa staining of sorted and
cytocentrifugated CD1b
+ L-DCs (D). Expression of mRNA for CCR7, CD103 and DC-SIGN by sorted CD1b
+ L-DCs (1, 3, 5 respectively) and in cDNA
control (2, 4, 6 respectively) (E). Uptake of FITC-ovalbumin (FITC-OVA) or GFP-Salmonella by CD1b
+ L- DCs. Lymph cells (1610
6 cells) were incubated
with FITC-OVA for 1h at 4uCo r3 7 uC, or with GFP-Salmonella for 30 min at 37uC, followed by CD1b labelling. CD1b
+ L- DC subset was gated on lymph
cells and FITC-OVA fluorescence shown on dot plots F and G. Total L-APC were gated on SSC/FSC and the cell population negative for lymphocyte
markers. Quadrants were then defined on the CD1b
+ and CD1b
- subsets and GFP-Salmonella fluorescence shown on dot plot H.
doi:10.1371/journal.pone.0030430.g001
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5% saccharose and 1% BSA (A9647, Sigma) at room temperature
for 60 min. Samples and recombinant IFN-c diluted in PBSTw
supplemented with 1% BSA (dilution buffer) were added (100 ml/
well) and incubated at room temperature for 60 min. Washing
with PBSTw was repeated between each following step. The anti-
IFN-c:biotin-conjugated CC302 mAb (Serotec) was added
(100 ml/well) at 1 mg/ml in dilution buffer and incubated at room
temperature for 60 min. Plates were incubated at 37uC for 60 min
with horseradish peroxidase-conjugated extravidin (E2886, Sigma-
Aldrich) (100 ml/well) diluted at 1/1000 in dilution buffer.
Peroxidase activity was revealed by adding tetramethyl benzidine
substrate (TMB) (T8665, Sigma). The reaction was stopped by the
addition of 0.5M H2SO4 (50 ml/well) and absorbance was read at
405 nm.
IL-4 detection was similarly performed using anti-bovine
CC313 (1 mg/ml) and CC314 (1 mg/ml) mAbs (Serotec) [26].
IL10 was detected by ELISA using the anti-ruminant CC318 and
CC320 mAbs (Serotec) as described previously [27].
Standard curves were generated for each cytokine assay with
recombinant ovine IFN-c, IL-4 and IL-10 (kindly provided by Dr
S. Wattegedera, MRI, Scotland). Cytokine concentrations were
expressed in IU/ml.
Statistical analyses
In the experiments performed with several sheep, the statistical
analysis used was carried out with the package ‘‘nparLD’’ designed
to perform non-parametric analysis of longitudinal data in factorial
experiments [28]. In the case of the repetition of several
independent experiments performed with sorted CD1b
+ L-DCs
and T cells sampled at different times in the same sheep, we have
defined that results of proliferative response were representative of
a biological response when the ratio of antigen stimulated to
medium stimulated conditions was .2.
Results
Phenotyping and uptake capacities of migrating CD1b
+
L-DC at steady state
As two subsets of CD1b
+ L-DCs were found to phagocytose
Salmonella in vitro, CD1b
+ CD14
hi and CD1b
+ CD14
lo [17], the
phenotype of CD1b
+ L-DCs was characterized on cells in our
possession collected from a pseudo-afferent duct draining the skin
and to complete further a previous study [29]. CD1b
+ L-DCs were
all found positive for DC-specific markers, i.e., CD11c, MHCII,
CD205, CD44 and costimulatory molecules CD40, CD80, CD86,
and expressed strongly these molecules (Fig. 1B, 1C). The
expression of CD14 on CD1b
+ L-DCs was positive and relatively
homogeneous (Fig. 1C), in contrast to a previous study performed
in sheep [18], possibly due to the different sheep breeds used. The
clone VPM65 used may recognize a specific CD14 isoform
expressed on sheep L-DCs, as clones CAM36 and TUK4 did not
label sheep L-DCs [19,22]. The expression of the other CD26 and
SIRP-a markers on the majority of the cells demonstrated the
presence of both CD26
+ and SIRP-a
+ L- DC subsets in CD1b
+ L-
DCs. Moreover, CD1b
+ L-DCs expressed CCR7 mRNA as
migratory DCs, and CD103 mRNA (Fig. 1E) possibly as dermal
DCs, which have been described as CD11c
+CD11b
loCD103
+ in
mice [30], and related to the CD26
+ L-DC subset which has
functional similarities with CD8a-like DCs [17]. In contrast,
expression of CD11b and CD206 (Mannose receptor) was
observed on less than 20% of the CD1b
+ L-DCs, and the
antibody to human CD209/DC-SIGN did not react with cells,
whereas intestinal ovine DCs did [31], and despite the expression
of DC-SIGN mRNA (Fig. 1E).
We then investigated the ability of these cells to capture antigens
by measuring the endocytic uptake of soluble antigens as FITC-
OVA. More than 50% of CD1b
+ L-DCs were able to endocytose
soluble antigens (Fig. 1G). The capacity of CD1b
+ L-DCs to
phagocytose Salmonella was also assessed using GFP-Salmonella and
showed that within the CD1b
+ L-DC subset, 62% of the cells were
fluorescent, whereas only 15% of CD1b
2 L-DCs were fluorescent
(Fig. 1H).
Overall, CD1b
+ L-DCs have phenotypic features of mature
DCs, including those of several conventional DC subsets, and
functional abilities to uptake soluble antigens and Salmonella.
CD1b
+ L-DCs are able to present Salmonella antigens to
specific effector/memory CD4
+ T cells
The ability of CD1b
+ L-DCs to present bacterial antigens to
specific T cells, induced in vivo by SC infection of sheep by
Salmonella, was also investigated. To this end, we studied the
kinetics of blood T-cell activation following infection. CD4
+ and
CD4
2 T cells were isolated from the blood of three sheep at
different times between one and nine weeks after infection to assess
their capacity to be activated by CD1b
+ L-DCs primed in vitro with
Salmonella (data not shown). The variation in the multiplicity of
infection determined the optimal ratio to 100 Salmonella per DC to
Figure 2. Presentation of Salmonella antigens by CD1b
+ L-DCs
to autologous specific CD4
+ T cells. Sorted CD1b
+ L-DCs were
infected by Salmonella for 30 min, incubated for 24h and co-cultured
with autologous purified CD4
+ T cells at a ratio of 1:100. Cells were co-
cultured for six days and the proliferative response assessed by [
3H]-
thymidine incorporation and expressed as counts per minute (cpm).
Autologous CD4
+ (black symbols) or CD4
2 (white symbols) T cells were
either isolated from immune sheep 21 days after SC vaccination with
Salmonella (A) or from a non-immune sheep (B). Each symbol shape
represents data from a different sheep (A) or from three independent
experiments performed on one sheep (B). *** very significant difference.
doi:10.1371/journal.pone.0030430.g002
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highest specific proliferative response of CD4
+ T cells to CD1b
+ L-
DCs primed with Salmonella was observed 21 days after infection,
and no proliferative response was observed for CD4
2 T cells
(Fig. 2A). Under these conditions, CD1b
+ L-DCs primed in vitro
with Salmonella were able to activate a high proliferative response
(ratio Salmonella/Medium: 21.6) of CD4
+ T cells and a lower
response of CD4
2 T cells (ratio Salmonella/Medium: 4.9) isolated
from non-vaccinated sheep (Fig. 2B). The priming of CD1b
+ L-
DCs with inactivated Salmonella induced a lower proliferative
response of CD4
+ T cells than with live Salmonella (data not shown).
Thus, in vitro, CD1b
+ L-DCs alone are able to phagocytose,
process and present efficiently Salmonella antigens to effector/
memory CD4
+ T cells.
CD1b
+ L-DCs are efficient APC for the priming of naive T
cells
The CD1b
+ L-DCs were then tested for their ability to prime
the naive T-cell response. To this end, first an in vitro model of
allogeneic response was used. Four independent experiments were
performed with different sheep and showed that CD1b
+ L-DCs
were able to induce a proliferative response of blood CD4
+ T cells
with an optimal ratio of 20 effector cells per DC (Fig. 3A). This
proliferative response was associated with the production of
cytokines in the supernatants of CD4
+ T cell/CD1b
+ L-DC co-
cultures. IFN-c and IL-4 in a lesser extent, production was
detected in supernatants but IL-10 was not (data not shown),
demonstrating the predominance of the induced Th1-response
(Fig. 3B). CD1b
+ L-DCs were then tested for their ability to
stimulate the priming of allogeneic naive T cells. The naive T cells
were sorted by the expression of L-selectin (CD62L), the homing
receptor which allows their recruitment into organized lymphoid
tissues such as LN via high endothelium venules [32]. CD1b
+ L-
DCs were tested in two allogeneic experiments performed in one
sheep with CD62L
+ T cells. One of these experiments is
represented in figure 3C showing the intense proliferative response
of CD62L
+ T cells associated mainly with IFN-c production
(Fig. 3D). Thus, in vitro, CD1b
+ L-DCs alone are able to induce an
efficient allogeneic naive T-cell response.
To evaluate the potential of CD1b
+ L-DCs to present bacterial
antigens to naive T cells, we tested in vitro the capacity of CD1b
+ L-
DCs to process and present Salmonella to autologous CD62L
+ T
cells. One of the two experiments performed in one sheep is shown
in figure 4A and shows a high proliferative response of autologous
CD62
+ T cells (ratio Salmonella/Medium: 12) in co-culture with
CD1b
+ L-DCs infected by live Salmonella. This response was
Figure 3. CD1b
+ L-DCs are efficient APC for the priming of allogeneic naive T cells. Sorted CD1b
+ L-DCs were incubated at different ratios
with 10
5 allogeneic CD4
+ T cells (A) or CD62L
+ T cells (C), and tested for proliferation by [
3H]-thymidine incorporation after six days of culture. Data
express the median (quartiles) of counts per minute (cpm) from triplicates for each condition. After three days of culture, supernatants were sampled
and IFN-c (black bars) and IL-4 (grey bars) production analysed by ELISA (B, D). The results shown are from one representative experiment out of four
performed on different sheep (A) or out of two performed on one sheep(C).
doi:10.1371/journal.pone.0030430.g003
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IL-4 (Fig. 4B). The CD1b
+ DCs are thus able to present Salmonella
antigens to naive T cells efficiently.
Presentation of Salmonella Ag to CD4
+ T cells by
migrating DCs primed by mucosal vaccination with the
Salmonella Rv-6 strain
To demonstrate further the potential of CD1b
+ L-DCs to
process and present microbial antigens to T cells in vivo, the
conjunctival route was used to inoculate the S. Abortusovis Rv-6
strain vaccine and cannulation of the cervical pseudo-afferent
lymph was performed to collect CD1b
+ L-DCs before and after
inoculation. The phenotype of cervical CD1b
+ L-DCs was
analysed at steady state for three sheep, and no difference was
observed with the cutaneous CD1b
+ L-DC phenotype, either in
terms of the percentage of cells (Fig. 5A), or of MFI (data not
shown). The relative expression of CD103 and DC-SIGN mRNA
by cervical CD1b
+ L-DCs did not differ from that of cutaneous
CD1b
+ L-DCs (data not shown). After inoculation of Salmonella by
the conjunctival route, the proportion of CD1b
+ L-DCs did not
differ from that before inoculation and the intensity of CD1b
expression was similar. After Salmonella inoculation, the different
marker expression within the CD1b
+ L-DCs population did not
show any significant variation in the percentage of cells or in the
MFI (data not shown).
CD1b
+ L-DCs were then isolated at different times after
inoculation to assess their capacity to present Salmonella Ag by
analysing the proliferative response of autologous CD4
+ T cells.
The results of three independent experiments show a variable
proliferative response of CD4
+ T cells (ratio 16h/0h: 1.8, 8.5, 1.5
respectively), but no response of CD4
2 T cells, to CD1b
+ L- DCs
collected 16h after inoculation (fig. 5B). This suggests the in vivo
capture of Salmonella antigens by the CD1b
+ L-DCs, and their
capacity to present them directly to CD4
+ T cells.
Discussion
This study investigated the potential of migratory DCs to
present Salmonella Ag directly to T cells in LN, by challenging the
CD1b
+ L-DCs to present Ag of a Salmonella vaccine strain to
specific and naive T cells using an in vitro Ag presentation assay.
Although the CD1b
+ L-DCs display features of mature DCs, they
maintain the ability to uptake soluble Ag efficiently and to
phagocytose Salmonella. Our results show that CD1b
+ L-DCs alone
are able to present Salmonella antigens to specific autologous
effector/memory CD4
+ T cells and also to naive T cells associated
with a combined IFN-c and IL-10 response. This was also
observed for the priming of allogeneic naive T cells associated with
inducing both IFN-c and IL-4 responses. The potential of CD1b
+
L-DCs to present Salmonella Ag in vivo was also shown by collecting
CD1b
+ L-DCs from lymph after conjunctival inoculation of
Salmonella and by testing their ability to drive the amplification of
autologous CD4
+ T cells.
The migrating CD1b
+ L-DCs comprising a number of DC
subsets could originate from LC, dermal or blood-derived
monocytes. At steady state, the high percentage of the CD14
+
subset in CD1b
+ L-DCs shows that a large number of L-DCs
express the LPS receptor CD14, a monocyte/macrophage-specific
molecule, which could testify to the common monocyte-macro-
phages and DC precursors [33]. The CD26
+ L-DC subset which
has functional similarities with CD8a-like DCs [17], also
represents a high proportion of CD1b
+ L-DCs which could be
the cells producing CD103 mRNA and possibly dermal DCs
which have been described as CD11c
+CD11b
loCD103
+ in mice
[30]. In contrast, a low percentage of migrating CD1b
+ L-DCs
express CD11b, associated with weak expression of this molecule
on the cell surface, suggesting a small proportion of classical
dermal DCs within CD1b
+ L-DCs. Despite the high expression of
MHC II and co-stimulatory molecules, CD1b
+ L-DCs expressed
the endocytic receptor as CD206 and showed a good capacity to
endocytose soluble Ag. Moreover, 60% of the CD1b
+ L-DCs were
associated with fluorescent Salmonella, suggesting the high capacity
of CD1b
+ L-DCs to phagocytose our Salmonella vaccine strain.
This is in contrast to a previous study showing a limited ability of
L-DCs to phagocytose a virulent Salmonella strain [18].
Thus, steady-state migrating CD1b
+ L-DCs exhibit phenotypic
features of both mature and immature DCs keeping the ability, on
the one hand, to endocytose soluble antigens and phagocytose
Salmonella, and on the other hand, to express constitutively essential
molecules involved in T-cell priming.
Our data showed that CD1b
+ L-DCs were able to present
Salmonella antigens to specific effector/memory CD4
+ T cells
efficiently. In vitro they were also capable of priming autologous
naive T cells to Salmonella antigens and of priming allogeneic naive
T cells. However, the inactivated vaccine strain amplified CD4
+
autologous T cells less efficiently than the live vaccine strain. This
is in line with a previous study reporting that live virulent Salmonella
Typhimurium induced a greater up-regulation of the co-
stimulatory molecules than killed Salmonella [34]. The T-cell subset
Figure 4. Presentation of Salmonella antigens by CD1b
+ L-DCs
to autologous naive CD62L
+ T cells. Sorted CD1b
+ L-DCs were
infected by Salmonella for 30 min, incubated for 24h and co-cultured
with autologous purified CD62L
+ T cells at a ratio of 1:100. Cells were
co-cultured for six days and the proliferative response assessed by [
3H]-
thymidine incorporation (A). Data express the median (quartiles) of
counts per minute (cpm) from triplicates for each condition. After three
days of culture, supernatants were sampled and IFN-c (black bars) and
IL-10 (grey bars) production analysed by ELISA (B). The results shown
are from one representative experiment out of two performed on one
sheep.
doi:10.1371/journal.pone.0030430.g004
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+ T cells, and
CD1b
+ L-DCs directed the cytokine responses towards both IFN-c
and IL-10. These results are in line with numerous studies carried
out in mice on the immunity to Salmonella infection [35] and a few
studies performed in sheep [13,36]. Moreover, CD1b
+ L-DCs
were potentially able to induce IFN-c and IL-4 responses in the
allogeneic reaction. This suggests the potential of these physiolog-
ically derived migrating DCs to modulate their response according
to the Ag encountered. As a possible Ag delivery vehicle, this
Salmonella vaccine strain may offer a good tool to drive the immune
response towards a balanced IFN-c and IL-10 response.
To assess the relevance of our data obtained from an in vitro
model of Ag presentation, we challenged L-DCs collected from
sheep inoculated with our Salmonella vaccine strain. The phenotype
of L-DCs did not change significantly after conjunctival inocula-
tion with the Salmonella vaccine strain, in contrast to the increase
observed in CD1b and CD14 expression on L-DCs exposed in vitro
to a virulent strain of Salmonella [18]. These differences could be
related to the attenuated virulence of the Salmonella vaccine strain,
but no change was observed in the flow of L-DCs, in contrast to
the recruitment of CD1b
+ L-DCs observed after SC injection of
the same strain of Salmonella vaccine in oral mucosa [19]. This
suggests that the inoculation route could modify the traffic of
phagocytes in response to the vaccine strain and to set up the
appropriate immune response. In the case of the SC injection, the
inflammatory signals induced could trigger the rapid recruitment
of granulocytes, monocytes and DCs observed in the lymph [19].
On the other hand, conjunctival administration results in a rapid
local control of bacteria by non-specific defences, as previously
described with the attenuated Rev1 vaccine strain of Brucella
melitensis [37], and induces only a minor effect on the lymph traffic
with no associated inflammatory response. However, whatever the
administration route for the doses used, this vaccine strain is
completely cleared in the regional draining LN and is able to
induce adaptive protective immunity in pregnant ewes [13]. The
CD1b
+ L-DCs collected after conjunctival administration were
able to induce a low, but reproducible, amplification of autologous
CD4
+ T cells, suggesting that these CD1b
+ L-DCs had processed
in vivo Salmonella Ag and could present them to T cells. This study
did not investigate the processing of Salmonella Ag in vivo, but we
can postulate that the T cells could phagocytose and process
Salmonella directly from the conjunctiva and/or in the lymph, or
acquire Ag from Salmonella phagocytosed and killed by granulo-
cytes and monocytes. The main conclusion is that CD1b
+ L-DCs
in our model present potential characteristics of APC to initiate by
themselves T-cell priming in the LN, without excluding the
involvement of LN-resident DCs. These migrating CD1b
+ L-DCs
are able to uptake, process and present Ag to T cells and to
modulate their response according to the Ag encountered. They
could be used as target cells for driving immune activation in
vaccinal strategies.
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